ABetaL34V amyloidosis

ABetaL34V amyloidosis is an extremely rare hereditary form of amyloidosis caused by a specific mutation (Leu34Val, also written as L34V) in the APP gene, which provides instructions for making amyloid beta protein. In this condition, an abnormal form of amyloid beta protein builds up in the walls of blood vessels in the brain, a process known as cerebral amyloid angiopathy (CAA). Over time, this protein deposit weakens blood vessel walls and can lead to recurrent strokes caused by bleeding in the brain (hemorrhagic strokes), as well as progressive cognitive decline and dementia. The condition is also sometimes referred to as hereditary cerebral amyloid angiopathy, Dutch-type variant or ABeta-related cerebral amyloid angiopathy, though the L34V mutation is distinct from other well-known APP mutations. Symptoms typically begin in adulthood and may include sudden severe headaches, seizures, weakness on one side of the body, speech difficulties, and progressive memory loss. Because the amyloid deposits primarily affect brain blood vessels, the disease mainly impacts the nervous system, though systemic effects can sometimes occur. There is currently no cure for this condition. Treatment focuses on managing symptoms, preventing further strokes, and providing supportive care. Blood pressure control is important, and blood-thinning medications are generally avoided because they can increase the risk of brain bleeding. Rehabilitation services and cognitive support play a key role in maintaining quality of life.

Bring these to your next appointment

• Q1.How certain is the diagnosis, and should other family members be tested for this mutation?,What can I do to reduce my risk of having another brain hemorrhage?,Are there any medications I should avoid, including over-the-counter drugs like aspirin or ibuprofen?,What signs of a new stroke should I watch for, and when should I go to the emergency room?,Are there any clinical trials or experimental treatments available for this condition?,What kind of rehabilitation or therapy services would benefit me?,How should I plan for the future as this disease progresses?

Common questions about ABetaL34V amyloidosis